According to clinicaltrials.gov the trial is still

According to clinicaltrials.gov the trial is still active, not recruiting, at least that's the recruitment status.

https://www.clinicaltrials.gov/ct2/show/NCT02...amp;rank=2

We do know at least one patient that was dosed.

Amarantus Announces First Patient Dosed in Eltoprazine Phase 2b Study for Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia

https://www.amarantus.com/news/press-releases...ltoprazine

Yes, they did stop the recruitment, but I always wondered what happen to the people that started taking the drug.

A. Do they chase after them and say "spit it out"?
B. Give them a call and say "You know those pills we gave you last month. You might want to just stop taking them."
C. Tell them to go to Europe because the the trial is continuing there for a awhile longer.
D. Give them their business card and say "Off the record tell me how you re feeling when you run out of pills in 6 months."

Here's another trial that uses the world enabling, but slightly different.

Quote:

---

The CIT-07 trial was designed to be a license-enabling multicenter phase 3 clinical trial of a standardized, well-defined islet product, using a stringently defined, clinically relevant primary end point.

---

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317236/

At least they spelled "trial" right. You know there's someone that spells it as "trail" but they are an emotional basket case.